Neola Medical gets FDA Breakthrough Device Designation for Neola®
Neola Medical AB (publ) said the FDA granted Breakthrough Device Designation for Neola®, its non-invasive, continuous lung monitoring device for preterm born babies, intended to support timely detection of pot…
Neola Medical AB (publ) today announces that the U.S.
Food and Drug Administration (FDA) has granted Breakthrough Device Designation for Neola®, the Company’s medical device for non-invasive, continuous lung monitoring in preterm born babies, with the intended use to support timely detection of pot…